Adam R Kalbermatten bought $49K of KRMD stock

Adam R Kalbermatten, President-Chief Commercial Off of KORU Medical Systems, Inc. (KRMD), bought 12,500 shares of KRMD stock worth $49K, per an SEC Form 4 filed Jun 15, 2026.

It was an open-market purchase.

The trade happened on Jun 11, 2026, 4 days before it was made public.

KRMD has moved -22.8% since the trade date, from $4.00 to $3.09 (Nov 6, 2026 close).